drugset / Trial / NCT00127166

Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)

NCT00127166 ↗

Phase 3 Completed 154 enrolled Organon and Co
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of four weeks of treatment with two investigational drugs (oral versus inhaled administration) plus an inhaled medication in the treatment of airway constriction brought on by exercise in participants with asthma.

Timeline

Start
2005-12
Primary completion
2008-11
Completion
2008-11

Outcome

Met primary endpoint

paper Montelukast, compared with salmeterol, significantly reduced the mean maximum percentage decrease in FEV1 (10.6% vs 13.8%; P = .009) PMID 20568384 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 5 mg Oral
Subject Salmeterol Other / unclassified 50 ug Inhaled
Background Fluticasone Other / unclassified 100 ug Inhaled